VAERS Explorer
Back to explore

Report #2833401

Received Mar 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
VA
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RV1ROTAVIRUS (ROTARIX)GLAXOSMITHKLINE BIOLOGICALSUNK7E9Y2—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

A 1 month 4 days old female patient received a dose of Rotarix (liquid); This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-month-old female patient who received Rota (Rotarix liquid formulation) (batch number 7E9Y2, expiry date 30-MAY-2026) for prophylaxis. On an unknown date, the patient received Rotarix liquid formulation. On an unknown date, an unknown time after receiving Rotarix liquid formulation, the patient experienced inappropriate age at vaccine administration (Verbatim: A 1 month 4 days old female patient received a dose of Rotarix (liquid)). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-MAR-2025 A medical assistant called to report that they administered a dose of Rotarix (liquid) to a 1 month and 4 days old female patient which led to inappropriate age at vaccine administration. The reporter asked are there any side effects to consider?